Cargando…
Corrigendum to “Treatment of Breast and Prostate Cancer by Hypofractionated Radiotherapy: Potential Risks and Benefits” [Clin Oncol 27 (7) (2015) 420–426]
Autores principales: | Ray, K.J., Sibson, N.R., Kiltie, A.E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
W.B. Saunders
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603484/ https://www.ncbi.nlm.nih.gov/pubmed/28843381 http://dx.doi.org/10.1016/j.clon.2015.11.009 |
Ejemplares similares
-
Treatment of Breast and Prostate Cancer by Hypofractionated Radiotherapy: Potential Risks and Benefits
por: Ray, K.J., et al.
Publicado: (2015) -
Corrigendum to “Considerations for the Treatment of Oesophageal Cancer with Radiotherapy During the COVID-19 Pandemic” [Clin Oncol 32 (2020) 354–357]
por: Jones, C.M., et al.
Publicado: (2021) -
Corrigendum to “Harmonization of breast cancer radiotherapy treatment planning in the Netherlands” [Tech. Innov. Patient Support Radiat. Oncol. 19 (2021) 26–32]
por: Hurkmans, Coen, et al.
Publicado: (2023) -
Corrigendum to “Structural alterations of the brainstem in migraine” (Neuroimage Clin. 2017; 13: 223–227)
por: Chong, Catherine D., et al.
Publicado: (2017) -
Corrigendum to “Two compound techniques for total body irradiation” [Tech. Innov. Patient Support Radiat. Oncol. 21 (2022) 1–7]
por: Hansen, Anders T., et al.
Publicado: (2023)